Literature DB >> 19560081

Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation.

Masayuki Shimano1, Rei Shibata, Yasuya Inden, Naoki Yoshida, Tomohiro Uchikawa, Yukiomi Tsuji, Toyoaki Murohara.   

Abstract

BACKGROUND: Oxidative stress is associated with atrial fibrillation (AF). However, little is known about the relationship between serum markers of oxidation and electrical activity in patients with AF.
OBJECTIVE: The purpose of this study was to investigate the possible association between serum markers of reactive oxidative metabolism and atrial remodeling in paroxysmal and persistent AF.
METHODS: Derivatives of reactive oxidative metabolites (DROM), an index of oxidative stress, were measured in 306 consecutive patients with AF (225 paroxysmal, 81 persistent) undergoing radiofrequency (RF) catheter ablation. Filtered P-wave duration by P-wave signal-averaged ECG and levels of high-sensitivity C-reactive protein (CRP) as an inflammatory marker also were measured.
RESULTS: Patients were followed up for 1.2 +/- 0.8 years. DROM levels in patients with persistent AF were significantly higher than in patients with paroxysmal AF (341.6 +/- 85.5 Carratelli [Carr] units vs 305.0 +/- 77.7 Carr units, P <.001). DROM levels showed a tighter, positive correlation with filtered P-wave duration in persistent AF patients (r = 0.56, P <.001) than in all AF patients (r = 0.13, P <.05). DROM levels also showed a weaker but significant correlation with high-sensitivity CRP in patients with AF. Kaplan-Meier analysis revealed that the highest quartile of basal DROM levels exhibited a significantly higher AF recurrence rate after RF catheter ablation in patients with paroxysmal AF (P <.01).
CONCLUSION: Serum markers of oxidative stress reflect atrial conduction disturbance and predict AF recurrence after RF catheter ablation in paroxysmal AF patients. DROM could serve as a biomarker for predicting risk of AF recurrence after RF catheter ablation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19560081     DOI: 10.1016/j.hrthm.2009.03.012

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  34 in total

1.  Effect of tumor necrosis factor-α antagonists on oxidative stress in patients with Crohn's disease.

Authors:  Kazunari Yamamoto; Toshimi Chiba; Takayuki Matsumoto
Journal:  World J Gastroenterol       Date:  2015-09-21       Impact factor: 5.742

2.  Characterization of cardiac oxidative stress levels in patients with atrial fibrillation.

Authors:  Ayako Okada; Yuichiro Kashima; Takeshi Tomita; Takahiro Takeuchi; Kazunori Aizawa; Masafumi Takahashi; Uichi Ikeda
Journal:  Heart Vessels       Date:  2014-09-27       Impact factor: 2.037

3.  Atrial fibrillation in obstructive sleep apnea.

Authors:  Sandeep K Goyal; Abhishek Sharma
Journal:  World J Cardiol       Date:  2013-06-26

Review 4.  Oxidant stress promotes disease by activating CaMKII.

Authors:  Mark E Anderson
Journal:  J Mol Cell Cardiol       Date:  2015-10-22       Impact factor: 5.000

Review 5.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

Review 6.  Uric Acid and Cardiovascular Disease: An Update.

Authors:  Maria Lorenza Muiesan; Claudia Agabiti-Rosei; Anna Paini; Massimo Salvetti
Journal:  Eur Cardiol       Date:  2016-08

7.  Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation.

Authors:  Bernhard Richter; Marianne Gwechenberger; Ariel Socas; Gerlinde Zorn; Sulaima Albinni; Manfred Marx; Jutta Bergler-Klein; Thomas Binder; Johann Wojta; Heinz D Gössinger
Journal:  Clin Res Cardiol       Date:  2011-11-19       Impact factor: 5.460

8.  Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Jian Shan; Wenjun Xie; Matthew Betzenhauser; Steven Reiken; Bi-Xing Chen; Anetta Wronska; Andrew R Marks
Journal:  Circ Res       Date:  2012-07-24       Impact factor: 17.367

9.  Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.

Authors:  Larisa Emelyanova; Zain Ashary; Milanka Cosic; Ulugbek Negmadjanov; Gracious Ross; Farhan Rizvi; Susan Olet; David Kress; Jasbir Sra; A Jamil Tajik; Ekhson L Holmuhamedov; Yang Shi; Arshad Jahangir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

10.  Oral direct renin inhibitor aliskiren reduces in vivo oxidative stress and serum matrix metalloproteinase-2 levels in patients with permanent atrial fibrillation.

Authors:  Yoshizumi Takei; Minoru Ichikawa; Yoshiyuki Kijima
Journal:  J Arrhythm       Date:  2014-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.